Target intelligence / Profile preview

Dystrophin-related protein 2 (DRP2)

Target
DRP2
Molecular classification
Cytoskeletal-associated protein, member of the dystrophin protein family
01

Overview

Dystrophin-related protein 2 (DRP2) is a cytoskeletal-associated protein most closely related to dystrophin and utrophin, encoded by a gene on chromosome Xq22. DRP2 is expressed principally in the human brain and spinal cord and plays a role in maintaining membrane-associated protein complexes at sites of intercellular contact, particularly within the nervous system[3][4][7]. DRP2 is required for normal myelination and organization of the cytoplasm as well as Cajal band formation in myelinating Schwann cells[4]. Its structure resembles certain short isoforms of dystrophin; it is implicated in proper localization of proteins at the Schwann cell plasma membrane and in possible membrane-cytoskeleton interactions in the central nervous system[4]. Disorders associated with DRP2 dysfunction include spinal muscular atrophy type I and mitochondrial complex IV deficiency (nuclear type 1)[4]. Unlike classical drug targets, DRP2 is not known to function as a receptor, enzyme, transporter, or channel, and there are currently no drugs directly targeting DRP2 nor established use as a clinical biomarker or therapeutic target.

Other names
DRP2DRP-2Dystrophin related protein 2Dystrophin-related protein 2
02

Biological functions

Maintenance of membrane-associated complexesCytoskeleton–membrane interactionsMyelinationOrganization of cytoplasm in myelinating Schwann cells
03

Disease associations

Neurodevelopmental disordersPeripheral nervous system diseases (e.g., Spinal muscular atrophy, Type I)Mitochondrial complex IV deficiency (Nuclear type 1)

Beyond the preview

Go deeper on Dystrophin-related protein 2 (DRP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dystrophin-related protein 2 (DRP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call